Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have stated that they take no responsibility for the contents of the following announcement and make no representation as to its accuracy or completeness.

CSPC Pharmaceutical Group Limited (the “Company”) will hold a Board of Directors meeting on Thursday, 20 November 2025, to approve, among other matters, the unaudited third quarter results of the Company and its subsidiaries for the nine months ended 30 September 2025. The announcement date is 10 November 2025.

As of the date of the announcement, the Board of Directors consists of Mr. CAI Dong Chen, Mr. ZHANG Cuilong, Mr. WANG Zhenguo, Mr. WANG Huaiyu, Dr. LI Chunlei, Dr. YAO Bing, Mr. CAI Xin, and Mr. CHEN Weiping as Executive Directors; and Mr. WANG Bo, Mr. CHEN Chuan, Prof. WANG Hongguang, Mr. AU Chun Kwok Alan, Mr. LAW Cheuk Kin Stephen, and Ms. LI Quan as Independent Non-executive Directors.